MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives
Mesenchymal stem cells (MSCs) are considered to be a powerful tool in the treatment of various diseases. Scientists are particularly interested in the possibility of using MSCs in cancer therapy. The research carried out so far has shown that MSCs possess both potential pro-oncogenic and anti-oncoge...
Main Authors: | Monika Szewc, Elżbieta Radzikowska-Bűchner, Paulina Wdowiak, Joanna Kozak, Piotr Kuszta, Ewa Niezabitowska, Joanna Matysiak, Konrad Kubiński, Maciej Masłyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/5/2745 |
Similar Items
-
Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids
by: Mostafa M. Ghorab, et al.
Published: (2016-02-01) -
Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents
by: Sapavat Madhavi, et al.
Published: (2017-02-01) -
Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
by: Zhenxi Niu, et al.
Published: (2022-06-01) -
Medicinal Chemistry of Quinazolines as Anticancer Agents Targeting Tyrosine Kinases
by: Mohamed F. Zayed
Published: (2023-03-01) -
Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs
by: Andreas Robert Rudolf Weiss, et al.
Published: (2019-06-01)